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ABSTRACT
Introduction. Screening tests are a key step in the diagnosis of dementia and should therefore be highly sensitive to the detection of 
mild neurocognitive disorders (NCD). The Mini Mental State Examination (MMSE) is the most commonly used screening method. The 
Montreal Cognitive Assessment (MoCA) is a newer and less well-known screening tool, which has none of the limitations of the MMSE. 
Aim. The aim of this study was to analyse the reliability of the Polish versions of MoCA 7.2 vs MMSE in the detection of mild NCD 
among people aged over 60.
Material and methods. The study was carried out at the Department and Clinic of Geriatrics from September 2014 to March 2017. 
The study included 281 participants, 91 of whom were assigned to the group without NCD. The other 190 had been diagnosed with 
mild NCD.
Results. In the analysis of the ROC curve of the MoCA 7.2 results, the AUC was 0.925 (p < 0.001). The optimal cut-off point for mild NCD 
was 23/24 points, with sensitivity and specificity of 83.2% and 79.1%. In the ROC curve of MMSE results, the AUC was 0.847 (p < 0.001). 
The optimal cut-off point for mild NCD was 27/28 points, with sensitivity and specificity of 75.8% and 66.7%. The difference between 
AUC MoCA 7.2 and MMSE was 0.078 (p = 0.036).
Conclusions. MoCA 7.2 detects mild NCD with more sensitivity than MMSE. We recommend using the cut-off point for MoCA of 23/24 
points, because this is characterised by a higher sensitivity than the previously recommended cut-off point of 25/26 points. For the 
MMSE, the recommended cut-off point should be 27/28, which gives greater diagnostic accuracy than the previously recommended 
25/26 points. 
Key words: mild neurocognitive disorder, Mini Mental State Examination, Montreal Cognitive Assessment, screening tests
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Introduction
 Poland as a society is dealing with a progressive ageing 
of its population. Based on demographic forecasts from the 
Central Statistical Office, it is expected that the percentage of 
the total population aged 65 and over will be 20.3% in 2030, 
and as much as 32.7% by 2050 [1]. It is well-recognised that 
such significant and progressive changes in the demographic 
structure will increase the prevalence of dementia [2], which is 
the third most common cause of mental disorders in old age [3].
One of the methods to deal with this challenge is to 
improve medical care in the field of diagnostics, treatment 
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and rehabilitation of the elderly with suspected cognitive 
impairment [3]. In the diagnostic area, identification of mild 
neurocognitive disorders (mild NCD) [2], which are charac-
terised by cognitive impairment with minimal impairment 
of complex daily activities is recommended [4]. Mild NCD is 
also considered a dementia prodrome, where the annual risk 
of conversion into Alzheimer’s Disease (AD) is 10–15% [5].
Fluorine-18-Fluorodeoxyglucose Positron Emission To-
mography imaging (18F-FDG PET) is considered the best diag-
nostic tool (88.9% sensitivity; 84.9% specificity) in predicting 
mild NCD to AD conversion [6]. The use of 18F-FDG PET in 
differential diagnosis gives the possibility of early identification 
of the preclinical phase of AD, increasing diagnostic precision 
and helping to monitor the effectiveness of treatment [7].
On the other hand, screening tests are used for an initial, 
cursory assessment of the overall level of cognitive activity, 
which are the basis for the selection of people for whom further 
diagnostic procedures should be undertaken [8]. The use of 
cognitive tests is also recommended in the current diagnostic 
criteria of mild NCD [4, 9]. They should be characterised by 
high sensitivity and specificity in the detection of discrete cog-
nitive disorders [10]. In addition, the scores used in screening 
tests should be based on the most up-to-date normative data 
available characterising a specific population. 
Conclusions regarding the results of neuropsychological 
assessment often come about by comparing test results with 
normative data. Normative data is useful for taking into 
account variables that can affect test performance (e.g. demo-
graphic factors) to obtain accurate and relevant results. [11].
The Mini Mental State Examination (MMSE) is the most 
commonly used screening tool in clinical practice today [12]. 
But increasing attention has been drawn to the insufficient 
diagnostic sensitivity of MMSE and the pressing need to 
introduce into routine use other screening methods to assess 
cognitive functions in the elderly. This is evidenced by the 
latest meta-analysis of the diagnostic effectiveness of cognitive 
screening tests for the detection of mild NCD [13]. The MMSE’s 
doubtful diagnostic screening efficacy in identifying mild NCD 
has contributed to the development of alternative methods. 
One of these is the Montreal Cognitive Assessment (MoCA), 
which according to the authors has none of the restrictions 
encountered in the MMSE [14]. MoCA, originally developed 
as a short tool to assess cognitive performance, i.e. to help GPs 
to detect mild NCD, is increasingly being used in clinical and 
research settings [15]. Our own analysis of bibliographic data-
bases showed no scientific reports of a validation character of the 
Polish version equivalent to MoCA 7.2. In addition, the authors 
of the Polish adaptation of MoCA 7.2, Gierus et al. [16], stressed 
the need to carry out research on the diagnostic accuracy of the 
Polish adaptation of MoCA 7.2 in identifying NCD.
The aim of our study was to analyse the reliability of the 
Polish version of MoCA 7.2 as against the Polish version of 
MMSE in detecting mild neurocognitive disorders among 
people over 60 years of age.
 We hope that our study may help to expand understanding 
of the diagnostic reliability of the Polish version of the MoCA 
7.2 and MMSE tests, and may contribute to obtaining the latest 
normative data for the Polish elderly population.
Material and methods
Subjects
Our study was conducted in the Department of Geriatrics 
at the University Hospital No. 1 A. Jurasza in Bydgoszcz, Poland 
between September 2014 and March 2017. The total number of 
participants included was 281. The study identified a group of 
91 people without neurocognitive disorders (which we termed 
the group without NCD), and a group of 190 people with mild 
neurocognitive disorders (the group with mild NCD).
The study was approved by the Bioethical Committee of 
the Nicolaus Copernicus University in Toruń at the Collegium 
Medicum Ludwik Rydygier in Bydgoszcz. All participants were 
informed about the main assumptions of the study and gave 
their written consent to participate.
Research procedure
Study participants were admitted according to schedule to 
the Clinic for Comprehensive Geriatric Assessment (CGA). 
As part of the CGA’s procedure, neuropsychological, quality 
of life, functional and laboratory tests were carried out. Based 
on the participant’s overall assessment, the therapeutic team, 
consisting of a geriatrician, nurse, clinical neuropsychologist 
and physiotherapist, established the diagnosis of either mild 
NCD or no NCD. A group of experts identified the intensity of 
cognitive impairment (without NCD vs. mild NCD vs. severe 
NCD), not including the aetiology.
Subsequently, an independent researcher conducted the 
MoCA 7.2 test without being aware of the diagnosis of the 
therapeutic team. The participants were tested using the MoCA 
7.2 test in similar conditions: i) at a fixed time (10am-noon); ii) in 
an examination room; iii) in private; iv) with hearing and vision 
defects addressed and overcome; and v) with a median interval 
between MMSE and CDT tests and the MoCA 7.2 of two days.
A detailed analysis of the study participants’ medical his-
tory was conducted to obtain the following data: sociodemo-
graphic parameters (gender, age, education); anthropometric 
parameters (weight, height); the results of tests carried out 
as part of the Comprehensive Geriatric Assessment (MMSE, 
CDT, GDS, ADL, IADL); and the results of a neuropsychologi-
cal assessment (history, diagnosis without NCD vs mild NCD).
Clinical diagnosis
The inclusion criteria for our study were as follows: i) age 
60 or older; ii) scheduled admission to the Clinic for CGA.
The exclusion criteria for our study were as follows: i) 
major NCD diagnosed according to the Diagnostic and Sta-
tistical Manual of Mental Disorders Fifth Edition (DSM-5); ii) 
uncorrected hearing defects or total deafness; iii) uncorrected 
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vision defects or complete blindness; iv) significant depend-
ence in everyday life e.g. bedridden; and v) less than six years 
of formal education.
A diagnosis of mild NCD based on the DSM-5 diagnostic 
criteria was considered the criterion for inclusion in the group 
with mild NCD [4]. 
The inclusion criteria for the group without NCD were: i) 
no complaints about cognitive decline; ii) maintaining gen-
eral cognitive functioning; iii) maintaining independence in 
everyday activities; and iv) no mental illness.
Neuropsychological measures
MoCA is a tool developed in 2005 by Nasreddine et al. [14] 
for screening diagnosis of mild cognitive impairment (MCI), 
these days termed mild NCD. The Polish version equivalent 
to MoCA 7.2 was adopted by Gierus et al. [16]. During the 
adaptation of the Polish MoCA 7.2 equivalent, in order to min-
imise cultural differences, changes were made to the Memory 
subtest, replacing the words truck, banana, violin, desk and 
green contained in the original version of MoCA 7.2 with the 
words tap, pineapple, violin, table and white. As in the orig-
inal English version, 25/26 points was determined to be the 
recommended cut-off point identifying mild NCD. The final 
MoCA 7.2 result is correlated with participants’ years of formal 
education. For each year of education fewer than 12 years, one 
additional point is taken into account [14]. MoCA 7.2 is not 
used in Polish geriatric practice as part of CGA.
The MMSE was developed in 1975 by Folstein et al. [17] as 
a screening tool for assessing cognitive status, and is currently 
most commonly used in the detection of mild and major NCD. 
MMSE has recently been subject to copyright restrictions [18]. 
26/27 points is the recommended identification cut-off point 
[17]. The MMSE scale is part of the CGA [19].
The Clock Drawing Test (CDT) developed as an auxil-
iary screening instrument for the purpose of differentiating 
cognitive patients from patients with cognitive impairment, 
especially the elderly [20]. In our own study, the Shuman et 
al. method [21] was used, taking into account a scoring scale 
of 0–5 points, where 4–5 points was classified as ‘normal’, and 
0–3 points as ‘invalid’. The CDT is included in the CGA [19].
The Geriatric Depression Scale 30 (GDS-30) was devel-
oped in 1983 by Yesavage et al. [22] as a screening tool for 
assessing depression in the elderly. The original version of 
GDS consists of 30 questions to be answered “Yes” or “No”, 
which are scored according to an answer key. In GDS, a score 
of 0–10 points means no depression, 11–20 points slight de-
pression, while 21–30 points signals major depression. In our 
own study, all participants completed the GDS questionnaire 
with the help of another person. The GDS scale is carried out 
as part of the CGA [19].
Functional measures
Activities of Daily Living (ADL) was developed in 1970 by 
Katz et al. [23] as a tool to assess the proficiency of basic skills 
of everyday life. The ADL scale, constructed from six questions, 
is based on a 7-step scoring procedure, where for each action 
0, 0.5 or 1 point is awarded. A score of 5–6 points indicates 
properly maintained fitness, 3–4 points moderate disability, 
while ≤ 2 points signals significant malfunction. A low score 
indicates an inability to function independently and the need 
for help from other people [24].
 Instrumental Activities of Daily Living (IADL) is a tool 
constructed in 1969 by Lawton et al. [25] to verify the ef-
ficiency of complex everyday activities. In our own study, 
a 27-point scale was used. A score of 27-19 points characterises 
self-sufficient people, 18-10 points moderately disabled people 
requiring assistance, and 9-1 points identifies people who are 
significantly dependent on others. Each tested parameter of in-
strumental functioning is assessed in terms of the individual’s 
ability to perform it. For each parameter three points can be 
obtained, meaning they can function without help, two points 
means they need some help, and one point signals that they 
are unable to function without help.
The DSM-5 diagnostic criteria for mild NCD include as-
sessment of the subjects’ independence by assessing efficiency 
in basic and complex daily activities, so we decided to use the 
ADL and the IADL [4]. Both these scales are also included in 
the CGA [19].
Statistical analysis
 Statistical development of the collected research material 
was initiated by examining the compatibility of the distribution 
of analysed variables with the normal distribution, using the 
Shapiro-Wilk test. To compare quantitative variables between 
groups with non-normal distribution, the Mann-Whitney 
U test was used. For graphical presentation of the results 
obtained, box-plot charts were used, where the box indicates 
a standard error and the whisker a 95% confidence interval. 
The diagnostic value of MoCA 7.2 and MMSE in the detec-
tion of mild NCD was analysed by the ROC curve method. 
Statistical significance level was set at p ≤ 0.05. Statistica v. 
13 PL software for Windows was used for statistical analysis.
Results
Study sample
This study involved 281 participants; 91 were included in 
the group without NCD, while 190 were included in the group 
with mild NCD (Tab. 1).
Characteristics of sociodemographic data show that the 
median age in the group with mild NCD was 78 years (95% 
Confidence Interval, CI, range 77.3-79.2), while in the group 
without NCD it was 74 years (95% CI, range 72.3-75.8). The 
difference between the two groups turned out to be statistically 
significant (p < 0.001).
 The results of tests carried out as part of the CGA showed 
that statistical differences between the groups (p < 0.01) oc-
curred in IADL, CDT and GDS-30. The median IADL score 
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Table 1. Characteristics of group with mild NCD vs group without NCD
Mild NCD  
(n = 190)
Without NCD  
(n = 91)
Mean Median (-) 95%CI (+) 95%CI Mean Median (-) 95% CI (+) 95% CI p
Weight (kg) 72.8 73 70.9 74.7 71.5 71 68.8 74.2 0.48
Height (cm) 158.7 158 157.4 160.0 161.1 160 159.7 162.6 0.02
BMI (kg/m2) 28.9 29 28.2 29.6 27.5 27 26.5 28.6 0.01
Age (years) 78.2 78 77.3 79.2 74.1 74 72.3 75.8 < 0.001
ADL (points) 5.7 6 5.7 5.8 5.8 6 5.8 5.9 0.06
IADL (points) 23.7 25 23.1 24.2 25.4 27 24.8 26.1 < 0.001
CDT (points) 3.3 3 3.1 3.5 4.5 5 4.3 4.7 < 0.001
GDS-30 (points) 9.2 8 8.4 10.0 6.7 6 5.6 7.7 < 0.001
Years of education 10.8 11 10.4 11.3 12.9 12 12.1 13.6 < 0.001
Sex Women (n) Women (%) Men (n) Men (%) Women (n) Women (%) Men (n) Men (%) < 0.001
140 74 50 26 78 86 13 14
NCD — neurocognitive disorders; CI — Confidence Interval; BMI — Body Mass Index; AD — Activities of Daily Living; IADL — Instrumental Activities of Daily Living; CDT — Clock Drawing Test; GDS-30 — Geria-
tric Depression Scale-30; P — probability
in the group with mild NCD was 25 points (95% CI, 23?.1-
24.2), and in the group without NCD it was 27 points (95% 
CI, 24?.8-26.1). The median CDT score in the group with 
mild NCD was 3 points (95% CI, 3.1-3.5), while in the group 
without NCD it was 5 points (95% CI, 5-4.3). The median 
GDS-30 score in the group with mild NCD was 8 points 
(95% CI, 8.4-10.0), while in the group without NCD it was 
6 points (95% CI, 5.6-7.7).
Analysis of MMSE and MoCA 7.2 cognitive 
domains
 Analysis of each studied cognitive function in MMSE 
using the Mann-Whitney U test showed that all domains ex-
cept ‘Naming and Repetition’ and ‘Constructive Praxis’ were 
characterised by a significant difference in results between 
the two groups.
The median MMSE score in the group with mild NCD 
was 27 points (95% CI, 26.38-27.06), while in the group 
without NCD it was 29 points (95% CI, 28.42-29.00). The 
difference between the two groups was statistically significant 
(p < 0.001) (Tab. 2).
However, analysis of each cognitive function studied in 
MoCA 7.2 showed that all cognitive domains were characterised 
by a significant difference in results between the two groups.
The median MoCA 7.2 score in the group with mild 
NCD was 23 points (95% CI, 21.37-22.28), while in the group 
without NCD it was 26 points (95% CI, 25.42-26.42). The 
difference between the two groups was statistically significant 
(p < 0.001) (Tab. 2).
Diagnostic reliability of MMSE and MoCA 7.2
The ROC curve for MMSE in detecting mild NCD was 
determined based on the results of sensitivity and specificity 
for eight cut-off points in the range 22/23 to 29/30. The Youden 
Index method, of which the result was 0.425, determined the 
optimal cut-off point to be 27/28 points. The optimal cut-off 
point had 75.8% sensitivity and 66.7% specificity where the 
positive predictive value (PPV) was 82.5% and the negative 
predictive value (NPV) was 57.1%. In contrast, the previously 
recommended threshold of 26/27 points obtained sensitivity 
and specificity of only 57% and 80% respectively (PPV — 
85.5%; NPV — 47.4%) (Tab. 3).
The ROC curve for MoCA 7.2 in detecting mild NCD was 
determined based on the results of sensitivity and specificity 
for 13 cut-off points in the range from 17/18 to 29/30. The 
optimal cut-off point was determined to be 23/24 points, the 
result was 0.623 and was characterised by 83.2% sensitivity 
and 79.1% specificity (PPV — 89.3%; NPV — 69.2%), while 
the recommended cut-off point for mild NCD, 25/26 points, 
had sensitivity and specificity of 96.3% and 45.1% respectively 
(PPV — 78.5%; NPV — 85.4%) (Tab. 3). 
Analysis of the Receiver Operating Characteristic (ROC) 
curve for MMSE in detecting mild NCD showed that Area 
Under the Curve (AUC) was 0.847 (p < 0.001). During anal-
ysis of the ROC curve, MoCA 7.2’s results in the detection of 
mild NCD AUC was 0.925 (p < 0.001). The difference in area 
under the AUC curves for MMSE and MoCA 7.2 was 0.078 (p 
= 0.036). This means that the AUC for MoCA 7.2 was signifi-
cantly greater than the AUC for MMSE (Fig. 1).
Discussion
The most common way of linking test results to the disease 
is to interpret the total result in relation to the cut-off point, so 
classifying the subject into a particular group [11].
The recommended cut-off point — similar to the original 
English version — for the Polish version of MoCA and MoCA 
7.2 is 25/26 points for mild NCD. 
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Table 2. Results of cognitive domains of MMSE and MoCA 7.2 tests for group with mild NCD vs group without NCD
 Mild NCD (n = 190) Without NCD (n = 91)









MMSE (points) 26.72 27 26.72 27.06 28.71 29 28.42 29.00 < 0.001
MMSE 1 Orientation 9.58 10 9.58 9.70 9.90 10 9.83 9.97 < 0.001
MMSE 2 Registration 2.99 3 2.99 3.01 3.00 3 - - 0.049
MMSE 3 Attention and Calculation 3.71 4 3.71 3.92 4.51 5 4.31 4.72 < 0.001
MMSE 4 Recall 1.98 2 1.98 2.12 2.59 3 2.45 2.73 < 0.001
MMSE 5 Naming and Repetition 2.89 3 2.89 2.93 2.93 3 2.88 2.99 0.220
MMSE 6 Executive Function 3.88 4 3.88 3.93 3.99 4 3.97 4.01 0.003
MMSE 7 Writing 0.91 1 0.91 0.95 0.99 1 0.97 1.01 0.020
MMSE 8 Constructive Praxis 0.77 1 0.77 0.83 0.80 1 0.72 0.88 0.550
MoCA 7.2 (points) 21.82 23 21.37 22.28 25.92 26 25.42 26.42 < 0.001
MoCA 1 Visuospatial / Executive 3.49 4 3.33 3.65 4.56 5 4.41 4.71 < 0.001
MoCA 2 Naming 2.58 3 2.50 2.67 2.79 3 2.69 2.89 0.002
MoCA 3 Attention 4.18 4 3.99 4.36 5.00 5 4.76 5.24 < 0.001
MoCA 4 Language 1.68 2 1.53 1.82 2.38 3 2.22 2.55 < 0.001
MoCA 5 Abstraction 1.61 2 1.52 1.69 1.81 2 1.72 1.91 0.004
MoCA 6 Delayed Recall 1.75 2 1.54 1.96 3.02 3 2.77 3.28 < 0.001
MoCA 7 Orientation 5.78 6 5.69 5.88 5.85 6 5.66 6.03 0.009
NCD — neurocognitive disorders; CI MMSE — Confidence Range, Short Mental State Assessment Scale; MoCA — Montreal Cognitive Assessment Scale; P — probability 
Table 3. Sensitivity, specificity, ACC, PPV, NPV, LR (+), LR (-), Youden Index for cut-off points for MMSE and MoCA 7.2
Cut-off points Sensitivity (%) Specificity (%) ACC (%) PPV (%) NPV (%) LR(+) LR(-) Youden Index
MMSE 22/23 12.4 98.9 40.6 95.8 35.3 11.129 0.886 0.113
23/24 19.9 98.9 45.7 97.4 37.4 17.903 0.810 0.188
24/25 25.3 97.8 48.9 95.9 38.8 11.371 0.764 0.230
25/26 38.7 94.4 56.9 93.5 42.7 6.968 0.649 0.332
26/27 57.0 80.0 64.5 85.5 47.4 2.849 0.538 0.370
27/28 75.8 66.7 72.8 82.5 57.1 2.274 0.363 0.425
28/29 90.9 34.4 72.5 74.1 64.6 1.386 0.265 0.253
29/30 100.0 0.00 67.4 67.4 - 1.000 - 0.000
MoCA 7.2 17/18 13.2 98.9 40.9 96.2 35.3 11.974 0.878 0.121
18/19 20.5 97.8 45.6 95.1 37.1 9.339 0.813 0.183
19/20 30.0 97.8 52.0 96.6 40.1 13.650 0.716 0.278
20/21 38.9 94.5 56.9 93.7 42.6 7.088 0.646 0.335
21/22 48.9 91.2 62.6 92.1 46.1 5.568 0.560 0.402
22/23 67.9 86.8 74.0 91.5 56.4 5.149 0.370 0.547
23/24 83.2 79.1 81.9 89.3 69.2 3.983 0.213 0.623
24/25 92.6 64.8 83.6 84.6 80.8 2.634 0.114 0.575
25/26 96.3 45.1 79.7 78.5 85.4 1.753 0.082 0.414
26/27 98.4 26.4 75.1 73.6 88.9 1.337 0.060 0.248
27/28 98.9 09.9 70.1 69.6 81.8 1.098 0.106 0.088
28/29 99.5 02.2 68.0 68.0 66.7 1.017 0.239 0.017
29/30 100.0 0.00 67.6 67.6 - 1.000 - 0.000
MMSE — Mini Mental State Examination; MoCA — Montreal Cognitive Assessment Scale; ACC — accuracy; PPV — Positive Predictive Value; NPV — Negative Predictive Value; LR (+) — Likelihood Ratio Positive; 
LR (-) — Likelihood Ratio Negative
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Figure 1. ROC curve analysis for MMSE vs MoCA 7.2
ROC — Receiver Operating Characteristic, MMSE — Mini Mental State Examination, MoCA — Montreal Cognitive Assessment Scale
Our own research showed that the commonly recom-
mended cut-off point had 98.7% sensitivity and 64.8% 
specificity. Magierska et al. obtained less satisfactory results, 
88.1% sensitivity and 40.5% specificity [26]. It can be con-
cluded that the recommended cut-off threshold it is not 
diagnostically sensitive in the detection of mild NCD for the 
Polish population.
However, in the Polish version of MMSE, the recommend-
ed cut-off point for identification of mild NCD is 26/27 points. 
The analysis of our own research shows very low sensitivity 
(43.4%) with higher specificity (64.8%). Similarly, Magierska 
reports the low diagnostic value of the Polish version of MMSE 
(sensitivity 28.6%; specificity 83.7%).
Based on our own results, it is certain that the most fa-
vourable cut-off point identifying mild NCD in MoCA 7.2 is 
23/24 points. Scoring above this figure is characterised by 
the highest diagnostic reliability (sensitivity 83.2%; speci-
ficity 79.1%). Magierska recommends a cut-off threshold of 
24/25 points (sensitivity 80.9%; specificity 54%).
 According to MMSE’s own results, the most favourable di-
agnosis of mild NCD is at the cut-off threshold of 27/28 points 
(sensitivity 75.8%; specificity 66.7%). Magierska also received 
the highest diagnostic value of mild NCD for a cut-off point of 
27/28 points (sensitivity 47.6%; specificity 72.9%).
In both studies, it was demonstrated that both the adapta-
tion of the Polish MoCA scale and the Polish MoCA 7.2 proved 
to be better screening tests for detecting mild NCD compared 
to the Polish version of MMSE from a statistical point of view. 
The discrepancies between studies may have arisen as a result 
of differences in the number of research samples and different 
methodological procedures.
A limitation of the Polish version of the MoCA 7.2 test 
is that there is little space for drawings in the visual-spatial 
domain. Vision problems, common among the elderly, often 
prevent the test from being performed correctly, and there is 
a risk of the final result being distorted.
Validation studies of MoCA versions from different coun-
tries: America [14, 27–29], Japan [30], Brazil [31], Turkey 
[32], Taiwan [33], China [34], South Korea [35], Romania 
[36], Spain [37], Malaysia [38], Singapore [39], and Sweden 
[40] have demonstrated, similarly to our results, the diagnos-
tic advantage of MoCA over the universally used MMSE in 
identifying mild NCD and sometimes insufficient sensitivity 
and specificity of the recommended cut-off points for mild 
NCDs in both tests.
The authors of the MoCA test, Nasreddine et al. [14] de-
termined 25/26 points to be the recommended cut-off point in 
the detection of MCI, obtaining satisfactory sensitivity (90%) 
and specificity (87%). Similar diagnostic parameters, for the 
American version of MoCA, were received by Martinelli et al. 
[41] (sensitivity 82.2%; specificity 92.3%) and Roalf et al. [28] 
(sensitivity 84%; specificity 79%) in their studies. 
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Subsequently, a study by Smith et al. [42] showed promis-
ing diagnostic sensitivity (80%) although with less satisfactory 
specificity (50%). Similar results were published by Damian et 
al. [27], noting 98% sensitivity and 52% specificity, whereas 
Luis et al. [43] considered the recommended cut-off point to be 
ineffective in detecting mild NCD (sensitivity 100%; specificity 
32%). A study of the Arabic version of MoCA by Rahman et 
al. [44] confirmed the high value of the recommended cut-
off threshold (sensitivity 85.7%; specificity 92.3%). However, 
a review of validation studies on Korean [45], Japanese [30], 
Chinese [34], Brazilian [31], Singaporean [39], Turkish [32] 
and Spanish [37] versions of MoCA showed that the recom-
mended cut-off threshold of 25/26 points is not characterised 
by appropriate sensitivity and specificity.
Luis et al. [43], examining the American version of MoCA, 
noted — exactly as we did in our own study — the highest di-
agnostic value of mild NCD at the cut-off point of 23/24 points 
(sensitivity 96%; specificity 95%). These results were confirmed 
by Damian [27], who recommended an identical optimal 
cut-off threshold of 23/24 points for the American version of 
MoCA (sensitivity 87%; specificity 76%).
Analysis of diagnostic performance of foreign language 
versions of MMSE in detecting mild NCD showed that the 
recommended cut-off point of 26/27 points — similarly to the 
research on the Polish version of MMSE — is characterised by 
unsatisfactory reliability. A meta-analysis by Mitchell et al. [46] 
conducted on the basis of five studies assessing the reliability of 
MMSE for mild NCD compared to healthy people (n = 1,857) 
showed that the recommended cut-off point is characterised 
by 63.4% sensitivity and 65.4% specificity.
Researchers of multilingual versions of MMSE have 
observed that increasing the cut-off threshold by one point 
above the recommended level significantly improves the 
diagnostic reliability of the MMSE test. The most frequently 
recommended level is 27/28 points for the identification of 
mild NCD. [27, 31, 43]
A meta-analysis by Tsoi et al. [47], containing 108 studies 
evaluating the diagnostic effectiveness of nine cognitive tests 
in the detection of mild NCD, showed that the MoCA test 
ranked second in terms of diagnostic relevance, prevailing 
over MMSE. Of the 35 studies analysing MoCA diagnostic 
values (n = 2,107 people with mild NCD), only 10 proved the 
officially recommended cut-off threshold (25/26 points). Other 
studies indicated other cut-off points, in the range of 20 to 
29 points. Researchers observed high heterogeneity of reliabil-
ity parameters for the recommended cut-off point (sensitivity 
ranged from 64% to 100%; specificity from 27% to 95%). 
Using a weighted average for the recommended threshold of 
25/26 points for the identification of mild NCD, the authors of 
the meta-analysis received 83% sensitivity and 75% specificity. 
In turn, the diagnostic reliability of MMSE was identified 
based on 58 studies (n = 4,613 people with mild NCD). The 
researchers observed the most commonly used cut-off value 
to be 26/27 points (11 studies). Other studies found different 
limits between 21 and 30. Furthermore, as in the MoCA 
test, various results were noted for the recommended cut-off 
point (sensitivity ranged from 13-97%, specificity 31-100%). 
Ultimately, they showed 71% sensitivity and 74% specificity.
A review of scientific reports assessing the diagnostic 
reliability of MMSE vs MoCA in identifying mild NCD ac-
cording to the cut-off point indicates a variety of results. The 
differentiation of MMSE and MoCA diagnostic reliability 
parameters for specific cut-off thresholds may result from the 
use of heterogeneous mild NCD diagnostic criteria. 
In our own meta-analysis of 20 studies, we observed 
that frequently the researchers used different versions of 
Petersen’s criteria [48]. The meta-analysis by Tsoi et al. [47] 
also confirmed the above outcomes. The heterogeneity of the 
results could have been due to the use of various adaptations 
and language versions of the tests. In addition, demographic 
variables i.e. age, gender, level of education, and ethnic dif-
ferences, could affect the diversity of MoCA performance 
parameters [32, 33, 49] and MMSE [50, 51] according to 
cut-off thresholds.
The diagnosis of mild NCD was based on the results of 
neurocognitive screening tests briefly assessing the efficiency 
of general cognitive functions, without taking into account 
the detailed assessment of individual cognitive functions 
along with determining the individual neurocognitive profile. 
In addition, no supplementary neuroimaging diagnostic 
tests were performed on people with mild NCD that could 
confirm the diagnosed disease and its aetiology with greater 
probability. The high cost of neuroimaging studies is the main 
reason for their lack of use in our own research. These meth-
odological imperfections were not the main assumption of 
the project. However, expanding the study in the future could 
increase the value of the study.
In conclusion, the analysis of own research shows that 
MoCA 7.2 can be used by GPs and in geriatric practice as 
a screening tool in detecting mild NCD. However, further re-
search is needed to look for the most optimal cut-off threshold 
for major NCD in the Polish population. In addition, there is 
a need to analyse MoCA 7.2 in terms of demographic variables 
and verify the results for these variables.
Conclusions
The MoCA 7.2 test is more effective in diagnosing mild 
NCD in people aged over 60 than the MMSE test. The optimal 
cut-off point for detecting mild NCD for the MoCA test is 
23/24 points, with 83.2% sensitivity and 79.1% specificity 
(PPV 89.3%; NPV 69.2%). The optimal cut-off threshold 
for detecting mild NCD for the MMSE test is 27/28 points, 
with 75.8% sensitivity and 66.7% specificity (PPV 82.5%; 
NPV 57.1%). 
Therefore, we propose a correction of the cut-off thresh-
olds for the Polish version of the MoCA 7.2 and MMSE tests 
in identifying mild NCD among people over 60 years of age.
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